Micardis® in Patients With Essential Hypertension

Boehringer Ingelheim

Status: Completed

Conditions: Hypertension

Treatments: Drug: Telmisartan tablets

Study type: Observational

Funder types: Industry

Identifiers

NCT02187705

502.322

Details and patient eligibility

About

The aim of this observational study was to supplement the data on efficacy, safety, and tolerability of telmisartan under daily conditions in hospitals

Enrollment: 1,688 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Patients with essential hypertension
• Minimum age of 18 years

Exclusion Criteria: Not applicable

Trial design

1,688 participants in 3 patient groups

Patients with normotension at baseline

Treatment:

Drug: Telmisartan tablets

Patients with essential hypertension at baseline

Treatment:

Drug: Telmisartan tablets

Patients with isolated hypertension at baseline

Treatment:

Drug: Telmisartan tablets